Lasa Supergenerics Peer Comparison

NSE: LASA | BSE: 540702

₹4.01

up-down-arrow ₹-0.21 (-4.98%)

As on 16-Nov-2026IST

Market cap

info icon

₹22 Cr

Revenue (TTM)

info icon

₹6 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

0.5

Div. Yield

info icon

0 %

Edit peer-selector-edit
Lasa Supergenerics Emcure Pharmaceuticals Neuland Lab Alivus Life Sciences Sudeep Pharma
Market cap (₹ Cr)
22 44,378 27,740 17,812 13,203
Revenue (₹ Cr)
6 10,234 2,307 2,684 710
Net Profit (₹ Cr)
-16.55 1,092.67 452.55 669.74 188.64
Net Margin (%)
-253.90 10.67 19.31 24.24 25.69
RoE (%)
-29.40 21.65 23.18 19.79 20.46
Price to Earnings
-- 40.58 61.30 26.60 70.10
Price-To-Book
0.47 8.30 13.67 4.91 13.79

Income Statement (₹ Cr)

Liabilities (₹ Cr)

Assets (₹ Cr)

Cashflow (₹ Cr)

Ratios

Profitability Ratios

Growth Ratios

Valuation Ratios

Solvency Ratios

Operating Efficiency Ratios

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month